With the deal, DNAFit and Prenetics gained exclusive global rights to Oxsed technology. Credit: Fernando Zhiminaicela / Pixabay.

Prenetics’s wholly owned UK entity DNAFit Life Sciences has acquired social venture company Oxsed to accelerate efforts of fighting Covid-19.

Based on research from Oxford University, Oxsed has developed a rapid Covid-19 testing platform.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

With this deal, DNAFit and Prenetics have gained exclusive global rights to Oxsed technology.

Named Oxsed RaViD Direct SARS-CoV-2 Test, it is a rapid diagnostic assay for the in vitro qualitative detection of SARS-CoV-2.

Funds received through the deal and access to Prenetics global network of resources will help Oxsed to provide rapid Covid-19 testing around the world.

According to the deal, Oxsed will continue to focus on ensuring access and availability of the test at a reasonable cost to low and middle-income countries.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Prenetics co-founder and group CEO Danny Yeung said: “We are immensely proud to collaborate with Oxford University and Oxsed. This is truly a game-changer and we aim to make the technology available to millions of people globally.

“Rapid, accurate, and frequent testing is one of our most important interventions to prevent large outbreaks and for the global economy.”

Based on reverse transcription, loop-mediated isothermal amplification (RT-LAMP) technology, the test is used to detect SARS-CoV-2 RNA.

The scalable and low-cost Covid-19 test detects the virus with great sensitivity and specificity and can be performed anywhere with results obtained in 15-30 minutes.

The testing kit has received CE mark in the EU and MHRA in the UK. Currently, it is used at London Heathrow for testing pre-departure passengers where Prenetics and Collinson / Swissport established a rapid testing facility.

In Hong Kong, Prenetics has set up a semi-automated laboratory and is using the Oxsed test as part of tests for arriving passengers.